Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05349916 · ClinicalTrials.gov registry record · NA
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
A NA study of Type2 Diabetes and Blood Sugar; High, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05349916 is a NA study of Type2 Diabetes and Blood Sugar; High that has completed, run by Purdue University. The registered enrollment target is 24 participants, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05349916, a NA study of Type2 Diabetes and Blood Sugar; High, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of the current study is to investigate whether consumption of soluble fibers (isomaltodextrin \[IMD\], partially digestible maltodextrin) and RS4 starch will lower postprandial glycemia as well as postprandial insulin in human subjects with relatively high fasting blood glucose, when consumed with a specific amount of digestible carbohydrate (rice porridge). The primary outcome of the study is the effect of fibers on postprandial blood glucose, whereas the secondary outcome will be its effect on postprandial blood insulin.
Conditions Studied
Interventions
- OTHER Control
- OTHER Isomaltodextrin Low Dose
- OTHER Isomaltodextrin High Dose
- OTHER GPC partially digestible maltodextrin
- OTHER Resistant Starch Type 4
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2022-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05349916
The ClinicalTrials.gov registry entry for NCT05349916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type2 Diabetes appearing as the primary indexed condition, and to 5 interventions - of which Control is the first listed.
NCT05349916 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05349916 about?
NCT05349916 is a clinical study titled "The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans". The main objective of the current study is to investigate whether consumption of soluble fibers (isomaltodextrin \[IMD\], partially digestible maltodextrin) and RS4 starch will lower postprandial glycemia as well as postprandial insulin in human subjects with relatively high fasting blood glucose, w...
What is the current status of trial NCT05349916?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-12-07. Estimated completion is 2022-03-09.
What conditions does trial NCT05349916 study?
This clinical trial studies the following conditions: Type2 Diabetes, Blood Sugar; High, Postprandial Hyperglycemia.
What interventions are being tested in trial NCT05349916?
The interventions under investigation include: Control (OTHER), Isomaltodextrin Low Dose (OTHER), Isomaltodextrin High Dose (OTHER), GPC partially digestible maltodextrin (OTHER), Resistant Starch Type 4 (OTHER).
Who is sponsoring clinical trial NCT05349916?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05349916 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
ACTIVE NOT RECRUITING · NA
-
Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy
COMPLETED · NA
-
Blueberry Consumption and Type 2 Diabetes
COMPLETED · NA
-
An Emotion-Focused Intervention for Glycemic Control in T2D
COMPLETED · NA
-
Dietary Approaches to Stop Hypertension for Diabetes
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.